Table 1.

Summary of used viral doses in this study

Viral dose levels (×1011 VP)
<11–55–1010–3030–40
Single treatments (n = 39)
 CGTG-102320
 Ad5-d24-GMCSF7
 Ad5-RGD-d24-GMCSF36
 ICOVIR-7
 Ad5/3-Cox2L-d24
 Ad3-hTERT-E1
Serial treatments (n = 21)
 CGTG-10226
 Ad5-d24-GMCSF13
 Ad5-RGD-d24-GMCSF213
 ICOVIR-7221
 Ad5/3-Cox2L-d243
 Ad3-hTERT-E11
All single CGTG-102 treatments (n = 72)a776
All serial CGTG-102 treatments (n = 51)a111
  • a8 patients received both single and serial treatment. Numbers in table indicate the numbers of treatments for each dose level.